16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Term ID

CHEBI:140264

Synonyms

(4Z,7Z,16S,17R,19Z)-16-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-17-hydroxydocosa-4,7,10,12,14,19-hexaenoic acid
16-cysteinyl,17-hydroxy-4Z,7Z,16S,17R,19Z-docosahexaenoic acid
PCTR3
protectin conjugate in tissue regeneration 3

Definition

A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a glycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialised proresolving mediators

References

PMID:25713027

Ontology

ChEBI ( EBI )

Relationships

is a type of: dicarboxylic acid docosanoid organic sulfide S-substituted L-cysteine secondary alcohol

dicarboxylic acid docosanoid organic sulfide S-substituted L-cysteine secondary alcohol Show first 5 Terms
has_role: human xenobiotic metabolite specialised pro-resolving mediator

human xenobiotic metabolite specialised pro-resolving mediator Show first 5 Terms
inverse is_conjugate_base_of: 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)

16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) Show first 5 Terms
is_conjugate_acid_of: 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)

16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) Show first 5 Terms

Phenotype

Phenotype resulting from 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Phenotype where environments contain 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Phenotype modified by environments containing 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Human Disease / Model Data